RPL32P9

Across TCGA pan-cancer cohorts, RPL32P9 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL32P9’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RPL32P9 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P9 is over-expressed in tumor, although a few such as KIRP and THCA show the opposite, repressed pattern.

KIRP, KICH, and LUSC are the cancer types where RPL32P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	II,III,IV	−0.410	<.001	6	view →
KICH	All	All	+1.216	<.001	4	view →
LUSC	Male	All	+0.070	.044	2	view →
LUAD	All	All	+0.067	.026	2	view →
THCA	Male	All	−0.044	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL32P9–KIRP

Open the KIRP breakdown →